Medable Showcases a Unified Approach to Digital Trials and Clinical Data Management at 2019 Society of Clinical Data Management (SCDM) Annual Conference

PALO ALTO, Calif.--()--Medable Inc., leading the transformation of clinical trials with a digital trials platform connecting patients, sites, and clinical trial teams, will demonstrate a number of integrated eClinical, telemedicine, and data management solutions at the 2019 Society of Clinical Data Management (SCDM) Annual Conference, booth #607, September 29 – October 2 in Baltimore, Maryland.

"Digital technologies have the ability to revolutionize clinical trials. As drug development and clinical trial programs increase in complexity, life science companies need an integrated platform, reducing time-consuming and costly data collection while increasing trial velocity," said Dr. Michelle Longmire, CEO & co-founder of Medable.

Medable team members will share insights and case studies highlighting how Medable is changing the paradigm through data-driven and virtual solutions. With consumer-grade apps, remote data collection, and real-time data availability, drug developers are able to bring new innovative therapies to patients faster.

Medable will be presenting in the following sessions:

Session 2: Beyond EDC: New opportunities and challenges with the diversification of data sources in clinical trials
Presenter: Jeff Beeler, VP Product Strategy, Medable
Presentation time: Monday, September 30, 11:15 AM – 12:15 PM

Session 5: Developing industry best practices and metrics for data from wearables, apps, and sensors
Presenter: Dr. Michelle Longmire, CEO & co-founder, Medable
Presentation time: Monday, September 30, 1:45 PM – 3:15 PM

Session 7: Hurdles and promises of zero-site trials — embracing the future through the data management lenses
Presenter: Mark Paul, Customer Success, Medable
Presentation time: Monday, September 30, 1:45 PM – 3:15 PM

Session 21: In a patient-centered trial, where do you store all the data?
Presenter: Tyler Pugsley, VP Life Sciences, Medable
Presentation time: Tuesday, October 1, 1:30 PM – 3:00 PM

Session 36: Digital revolution in healthcare and its impact on clinical data management
Presenter: Jeff Beeler, VP Product Strategy, Medable
Presentation time: Wednesday, October 2, 10:30 AM – 12:00 PM

About Medable

Medable is a privately held, venture-backed company headquartered in Palo Alto, California. Medable is on a mission to get effective therapies to patients faster by dramatically reducing the time from therapeutic development to market realization with digital data capture and real-time analytics that remove the complexities of clinical research to reduce trial timelines dramatically. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution. Medable's end-to-end digital trials platform allows patients, healthcare providers, clinical research organizations, and pharmaceutical sponsors to work together as a connected and empowered team in clinical trials and research.

For more information, visit www.medable.com and follow Medable on Twitter: @Medableinc

Contacts

Investors
Medable
investors@medable.com

Media
Letitia Rodley
letitia.rodley@medable.com

Release Summary

Medable Showcases a Unified Approach to Digital Trials and Clinical Data Management at 2019 (SCDM) Annual Conference

Contacts

Investors
Medable
investors@medable.com

Media
Letitia Rodley
letitia.rodley@medable.com